REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC
Share · US75886F1075 · REGN · 881535 (XNAS)
Overview Financial Indicators
494,00 USD
2,26 % 10,93 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 20:42

Current Prices from REGENERON PHARMACEUTICALS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
REGN
USD
06.06.2025 20:42
494,00 USD
483,07 USD
+2,26 %
XLON: London
London
0R2M.L
USD
06.06.2025 15:13
496,04 USD
483,07 USD
+2,68 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 0,55 % -11,55 % -29,27 % -36,39 % -50,84 % -17,25 %

Company Profile for REGENERON PHARMACEUTICALS INC Share

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma;Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.

Invested Funds

The following funds have invested in: REGENERON PHARMACEUTICALS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
2.094,68
Percentage (%)
4,91 %
Fund
iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)
Vol. in million
23.196,45
Percentage (%)
1,33 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)
Vol. in million
1.295,63
Percentage (%)
1,25 %
Fund
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Dist)
Vol. in million
33,86
Percentage (%)
1,25 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
3.294,59
Percentage (%)
0,90 %

Company Data

Name REGENERON PHARMACEUTICALS INC
Company Regeneron Pharmaceuticals, Inc.
Symbol REGN
Website https://www.regeneron.com
Primary Exchange XNAS NASDAQ
WKN 881535
ISIN US75886F1075
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Market Capitalization 60 Mrd.
Country United States of America
Currency USD
Employees 15,1 T
Address 777 Old Saw Mill River Road, 10591-6707 Tarrytown
IPO Date 2014-11-05
Dividends from 'REGENERON PHARMACEUTICALS INC'
Ex-Date Dividend per Share
20.05.2025 0,88 USD
20.02.2025 0,88 USD

Ticker Symbols

Name Symbol
Frankfurt RGO.F
London 0R2M.L
NASDAQ REGN

More Shares

Investors who REGENERON PHARMACEUTICALS INC hold also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
CROSSFIRST BANKSHARES INC
CROSSFIRST BANKSHARES INC Share
FLUIDRA S.A.
FLUIDRA S.A. Share
META PLATFORMS INC
META PLATFORMS INC Share
MICROSOFT CORP
MICROSOFT CORP Share
NATWEST MARKETS PLC 4.39% NTS 10/06/24
NATWEST MARKETS PLC 4.39% NTS 10/06/24 Bond
NVIDIA CORP
NVIDIA CORP Share
PAYPAL INC
PAYPAL INC Share
POLYMETAL INTL PLC
POLYMETAL INTL PLC Share
TESLA INC
TESLA INC Share
VERTEX PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025